Tolga Turgut - Concepedia

Concepedia

Author

Tolga Turgut

University of Manchester

Also Known As

T Turgut, Tolga I. Turgut, Tolga Turgut, Tolga ˙I. Turgut

11

Publications

1.2K

Citations

7

H-Index

33

Concepts

All Affiliations

University of Manchester University of Edinburgh National Health and Medical Research Council University of Liverpool Hacettepe University

TT

About

Tolga Turgut is an author at University of Manchester specializing in medicine, infection control, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	980
2	Social Sciences	1	1	12
3	Diabetes	1	1	337
4	Hospital Medicine	1	1	555
5	Neurology	1	1	12

Tolga Turgut

×

7

Publications

1.2K

Citations

7

H-Index

	Year	Citations
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial John R. Petrie, Nish Chaturvedi, Ian Ford, The Lancet Diabetes & Endocrinology Metabolic SyndromeType 1Diabetes ManagementCardiovascular DiseaseDiabetes	2017	337
A Double-Blind Controlled Study of Adjunctive Treatment With Risperidone in Schizophrenic Patients Partially Responsive to Clozapine A. Elif Anıl Yağcıoğlu, Berna Binnur Akdede, Tolga Turgut, The Journal of Clinical Psychiatry	2005	184
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial Saye Khoo, Richard J. Fitzgerald, Geoffrey Saunders, The Lancet Infectious Diseases VaccinationCovid-19 PandemicVaccine TrialVirologyMolnupiravir Versus Placebo	2022	76
A Double-Blind Study of Combination of Clozapine With Risperidone in Patients With Schizophrenia Berna Binnur Akdede, A. Elif Anıl Yag ̆ cıog ̆ lu, Köksal Alptekın, The Journal of Clinical Psychiatry	2006	48
T108. AUT00206, A NOVEL KV3 CHANNEL MODULATOR, REDUCES KETAMINE-INDUCED BOLD SIGNALLING IN HEALTHY MALE VOLUNTEERS: A RANDOMISED PLACEBO-CONTROLLED CROSSOVER TRIAL Francesca Perini, Jadwiga Nazimek, Shane McKie, Schizophrenia Bulletin NeuropsychologySynaptic TransmissionClinical NeuroscienceSocial SciencesMagnetic Resonance Imaging	2019	12
Randomised trial of genetic testing and targeted intervention to prevent the development and progression of Paget’s disease of bone Jonathan Phillips, Deepak Subedi, Steff Lewis, Annals of the Rheumatic Diseases	2023	12

Page 1